359 related articles for article (PubMed ID: 36835438)
1. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.
Chan AML; Cheah JM; Lokanathan Y; Ng MH; Law JX
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835438
[TBL] [Abstract][Full Text] [Related]
2. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells.
Del Vecchio F; Martinez-Rodriguez V; Schukking M; Cocks A; Broseghini E; Fabbri M
J Extracell Vesicles; 2021 Apr; 10(6):e12075. PubMed ID: 33815694
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
[TBL] [Abstract][Full Text] [Related]
4. Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors.
Choi JW; Lim S; Kang JH; Hwang SH; Hwang KC; Kim SW; Lee S
Molecules; 2020 Nov; 25(21):. PubMed ID: 33182448
[TBL] [Abstract][Full Text] [Related]
5. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.
Matchett EC; Kornbluth J
Front Immunol; 2023; 14():1265101. PubMed ID: 37818374
[TBL] [Abstract][Full Text] [Related]
7. A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
St-Denis-Bissonnette F; Cummings SE; Qiu S; Stalker A; Muradia G; Mehic J; Mediratta K; Kaczmarek S; Burger D; Lee SH; Wang L; Lavoie JR
J Extracell Vesicles; 2023 Dec; 12(12):e12387. PubMed ID: 38054534
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
Fabbri M
Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.
Ma F; Vayalil J; Lee G; Wang Y; Peng G
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
Front Immunol; 2021; 12():658698. PubMed ID: 34093547
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
Front Immunol; 2020; 11():631713. PubMed ID: 33679726
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
[TBL] [Abstract][Full Text] [Related]
13. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
14. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
Front Immunol; 2021; 12():771551. PubMed ID: 34956197
[TBL] [Abstract][Full Text] [Related]
15. Cancer extracellular vesicles as novel regulators of NK cell response.
Soriani A; Vulpis E; Cuollo L; Santoni A; Zingoni A
Cytokine Growth Factor Rev; 2020 Feb; 51():19-26. PubMed ID: 31837917
[TBL] [Abstract][Full Text] [Related]
16. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
17. iPSCs in NK Cell Manufacturing and NKEV Development.
Boyd-Gibbins N; Karagiannis P; Hwang DW; Kim SI
Front Immunol; 2022; 13():890894. PubMed ID: 35874677
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression.
Wang S; Sun J; Dastgheyb RM; Li Z
Front Immunol; 2022; 13():1045624. PubMed ID: 36405712
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles in carcinoma microenvironment.
Carvalho-Silva LT; Normando AGC; Sá JO; Dos Santos ES; De Rossi T; Busso-Lopes AF; de Oliveira AK; Paes Leme AF
Biochem Soc Trans; 2023 Apr; 51(2):771-781. PubMed ID: 37021691
[TBL] [Abstract][Full Text] [Related]
20. Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses.
Dosil SG; Lopez-Cobo S; Rodriguez-Galan A; Fernandez-Delgado I; Ramirez-Huesca M; Milan-Rois P; Castellanos M; Somoza A; Gómez MJ; Reyburn HT; Vales-Gomez M; Sánchez Madrid F; Fernandez-Messina L
Elife; 2022 Jul; 11():. PubMed ID: 35904241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]